ENANTA PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Watertown, MA
SEC filing record 1 source field available
Fiscal year end
30 September
ENANTA PHARMACEUTICALS INC has filed 827 SEC EDGAR filings since 21 Jun 2002

SEC filing history

Showing 651-675 of 826 matching filings.

Per page
25
Current page
27
4

PRIMARY DOCUMENT

Filing date
20 Feb 2015
Reporting date
19 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Feb 2015
Reporting date
19 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Feb 2015
Reporting date
19 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Feb 2015
Reporting date
18 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Feb 2015
Reporting date
13 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87373

SC 13G/A

Filing date
17 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87373

CONSONANCE CAPITAL MANAGEMENT LP

Filing date
17 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87373

SC 13G/A filing

Filing date
13 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87373

SC 13G/A

Filing date
10 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

8-K

Filing date
05 Feb 2015
Reporting date
05 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Jan 2015
Reporting date
16 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-35839

DEF 14A

Filing date
15 Jan 2015
Reporting date
19 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87373

ENANTA PHARMACEUTICALS INC.

Filing date
07 Jan 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jan 2015
Reporting date
06 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jan 2015
Reporting date
05 Jan 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

FORM 8-K

Filing date
22 Dec 2014
Reporting date
19 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Dec 2014
Reporting date
12 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

FORM 8-K

Filing date
11 Dec 2014
Reporting date
11 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Dec 2014
Reporting date
28 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Dec 2014
Reporting date
01 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-35839

FORM 8-K/A

Filing date
24 Nov 2014
Reporting date
24 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35839

FORM 8-K

Filing date
24 Nov 2014
Reporting date
24 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Nov 2014
Reporting date
20 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .